¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Chronic leukaemia of unspecified cell type"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • cell mass
    ¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º
  • cell organelle
    ¼¼Æ÷¼Ò±â°ü
  • cell respiration
    ¼¼Æ÷È£Èí
  • cell strain
    ¼¼Æ÷ÁÖ
  • cell substitution
    ¼¼Æ÷´ëü, Ç÷±¸´ëü
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • cell swelling
    ¼¼Æ÷Á¾Ã¢
  • cell-associated antibody
    ¼¼Æ÷¿¬°üÇ×ü
  • cell-bound antibody
    ¼¼Æ÷°áÇÕÇ×ü
  • cell-fixed antibody
    ¼¼Æ÷°áÇÕÇ×ü
  • cell-mediated cytolysis
    ¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
  • cell-mediated cytotoxicity
    ¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • cell-associated virus
    ¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
  • cell-mediated cytolysis
    ¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
  • cell-mediated cytotoxicity
    ¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • cell-mediated hypersensitivity
    ¼¼Æ÷¸Å°³°ú¹Î
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • cell-mediated reaction
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • cell-mediated response
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
  • cell-mediated lympholysis test
    ¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
  • centroacinar cell
    »ù²Ê¸®Á߽ɼ¼Æ÷
  • chief cell
    À¸¶ä¼¼Æ÷
  • Chinese hamster ovary cell
    Áß±¹ºñ´ÜÅÐÁã³­¼Ò¼¼Æ÷
  • chromaffin cell
    ģũ·Ò¼¼Æ÷, Å©·Òģȭ¼¼Æ÷
  • chromophilic cell
    »ö¼Òµë¼¼Æ÷, È£»ö¼Ò¼¼Æ÷
  • chromophobic cell
    »ö¼Ò¾Èµë¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • T cell replacing factor
    T¼¼Æ÷ ´ëüÀÎÀÚ
  • T cell/lymphocyte
    T ¼¼Æ÷/¸²ÇÁ±¸
  • T-cell
    T-¼¼Æ÷
  • T-cell differentiation
    T-¼¼Æ÷ºÐÈ­
  • T-cell growth factor
    T-¼¼Æ÷¼ºÀåÀÎÀÚ
  • Th cell
    Th¼¼Æ÷, Á¶·ÂT¼¼Æ÷, º¸Á¶T¼¼Æ÷
  • Ts cell
    ¾ïÁ¦T¼¼Æ÷
  • Tzanck cell
    Á¤Å© ¼¼Æ÷
  • abnormality of cell interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
  • accessory cell
    º¸Á¶¼¼Æ÷, ºÎ¼ö¼¼Æ÷
  • acidophilic cell
    È£»ê¼º¼¼Æ÷
  • acinar cell
    ¼±Æ÷ ¼¼Æ÷(àÍøàá¬øà)
  • acinar cell
    ¼±¹æ¼¼Æ÷(¡­á¬øà)
  • acinic cell carcinoma
    ¼±¹æ¼¼Æ÷¾ÏÁ¾(¡­á¬øàäßðþ)
  • acinic cell tumor
    ¼±¹æ¼¼Æ÷Á¾(¡­á¬øàðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • leukemia,myeloid, chronic
    ¸¸¼º °ñ¼ö¼º(Ø·àõ ÍéâÐàõ)
  • lung,chronic obstructive airway
    ¸¸¼º Æó¼â¼º ±âµµ Áú(Ø·àõ øÍáðàõ ѨԳ òó)
  • otitis media, chronic [=COM]
    ¸¸¼ºÁßÀÌ¿°
  • otitis media, chronic suppurative
    ¸¸¼ºÈ­³ó(¼º)ÁßÀÌ¿°
  • otitis mediawith effusion, chronic
    ¸¸¼º»ïÃâ(¼º) ÁßÀÌ¿°
  • pancreatitis,chronic relapsing
    ¸¸¼º Àç¹ß¼º(عà÷ î¢Û¡àõ)
  • pansinusitis, chronic
    ¸¸¼º¹üºÎºñµ¿¿°
  • pharyngitis, chronic
    ¸¸¼ºÀεο°
  • pharyngitis, chronic hypertrophic
    ¸¸¼ººñÈÄ(¼º) Àεο°
  • pharyngitis, chronic lateral
    ¸¸¼º¿ÜÃø(¼º) Àεο°
  • rhinitis, chronic
    ¸¸¼ººñ¿°
  • rhinitis, chronic hypertrophic
    ¸¸¼ººñÈÄ(¼º)ºñ¿°
  • simple chronic anemia
    ´Ü¼ø(¼º) ¸¸¼ººóÇ÷(Ó¤âíàõØ·àõÞ¸úì).
  • simple chronic anemia
    ´Ü¼ø(¼º) ¸¸¼ººóÇ÷(Ó¤âíàõØ·àõÞ¸úì)
  • sinusitis, chronic
    ¸¸¼ººÎºñµ¿¿°
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • Central glial cell
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] Á߽ɽŰ汳¼¼Æ÷
  • Glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁßÃß±³¼¼Æ÷
  • Mesothelial cell
    ÁßÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ÁßÇǼ¼Æ÷
  • Cuticular cell
    Áý²®Áú¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÇǼ¼Æ÷
  • Fenestrated endothelial cell
    â³»ÇǼ¼Æ÷
    [¿¾ ¿ë¾î] À¯Ã¢³»ÇǼ¼Æ÷
  • Interdental cell
    û°¢Ä¡¾Æ»çÀ̼¼Æ÷
    [¿¾ ¿ë¾î] ûġ°£¼¼Æ÷
  • Merkel`s cell
    Ã˰¢¼¼Æ÷
    [¿¾ ¿ë¾î] MerkelÃ˰¢¼¼Æ÷
  • Macula densa cell
    Ä¡¹Ð¹ÝÁ¡¼¼Æ÷
    [¿¾ ¿ë¾î] Ä¡¹Ð¹Ý¼¼Æ÷
  • Chromaffin cell
    ģũ·Ò¼¼Æ÷
    [¿¾ ¿ë¾î] Å©·Òģȭ¼¼Æ÷
  • Golgi cell
    Å«º°¼¼Æ÷
    [¿¾ ¿ë¾î] °ñÁö¼¼Æ÷
  • Large cell part
    Å«¼¼Æ÷ºÎºÐ
    [¿¾ ¿ë¾î] ´ë¼¼Æ÷ºÎ
  • Decidual cell
    Å»¶ô¸·¼¼Æ÷
    [¿¾ ¿ë¾î] Å»¶ô¸·¼¼Æ÷
  • Cuticular cell
    Åв®Áú¼¼Æ÷
    [¿¾ ¿ë¾î] ¸ð¼ÒÇǼ¼Æ÷
  • Matrix cell
    ÅйÙÅÁÁú¼¼Æ÷
    [¿¾ ¿ë¾î] ¸ð±âÁú¼¼Æ÷
  • Hair cell
    Åм¼Æ÷
    [¿¾ ¿ë¾î] À¯¸ð°¨°¢¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
FLC family life cycle; fatty liver cell; fetal liver cell; Friend leukemia cell
GCT general care and treatment; germ-cell tumor; giant cell thyroiditis; giant cell tumor
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
RCC radiological control center; rape crisis center; ratio of cost to charges; receptor-chemoeffector co...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
LIF Leukaemia Inhibitory Factor
LFS Leukaemia-free survival
MoMuLV Moloney Murine Leukaemia virus
MLL Mixed Lineage Leukaemia
MLV Moloney leukaemia virus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic subdural hemorrhage
    ¸¸¼º °æ¸·ÇÏ ÃâÇ÷
  • chronic superficial gastritis
    ¸¸¼º Ç¥À缺 À§¿°
  • chronic suppurative osteomyelitis
    ¸¸¼º È­³ó¼º °ñ¼ö¿°
    ±Þ¼º¿¡ ºñÇØ ¸ðµç Áõ»óÀÌ ¾àÇÏ´Ù. ±Þ¼ºÀ¸·Î ¾ÇÈ­°¡ ÁÖ±âÀûÀ¸·Î µÈ´Ù. Ä¡·á´Â Àß ¾ÈµÇ°í Àç¹ßÀÌ ½±´Ù.
  • chronic syndromes
    ¸¸¼º ÁõÈıº
  • chronic thyroiditis
    ¸¸¼º °©»ó¼±¿°
  • chronic toxicity
    ¸¸¼º µ¶¼º
  • chronic ulcer
    ¸¸¼º ±Ë¾ç
  • chronic ulcerative pulpitis
    ¸¸¼º ±Ë¾ç¼º Ä¡¼ö¿°
    ³ëÃâµÈ Ä¡¼ö Ç¥¸é¿¡ ³ó¾ç Çü¼º Áï ±Ë¾çÀÌ Æ¯Â¡ÀÌ´Ù. ¸¸¼º ¿°Áõ »óÅÂ. ÀþÀº »ç¶÷ÀÇ Ä¡¼ö, ³ªÀ̰¡ ¸¹Àº »ç¶÷¿¡¼­ ¾àÇÑ °¨¿°¿¡ ÀúÇ×ÇÒ ¸¸ÇÑ °Ç°­ÇÑ Ä¡¼ö¿¡ º¼ ¼ö ÀÖ´Ù.
  • chronic urethritis
    ¸¸¼º ¿äµµ¿°
  • chronic vasometer instability
    ¸¸¼º Ç÷°ü ¿îµ¿ ºÒ¾ÈÁ¤, ¸¸¼º Ç÷°ü ¿îµ¿ ºÒ¾ÈÁ¤Áõ
  • familial benign chronic pemphigus
    °¡Á·¼º ¾ç¼º ¸¸¼º õÆ÷â
  • following chronic infectious disease
    ¸¸¼º °¨¿° ÁúȯÀÇ ÃßÀû
  • pemphigus chronic vulgaris
    ¸¸¼º ½É»ó¼º õÆ÷â
    ÀÚ°¡ ¸é¿ª¼º ¼öÆ÷¼º ÁúȯÀ¸·Î¼­ ÁÖ·Î ÇÇºÎ¿Í Á¡¸·¿¡ ¹ß»ýÇÑ´Ù. Ư¡Àû ÀÚ°¡ Ç×üÀÇ ¸ñÇ¥ ÁöÁ¡Àº »óÇÇÀÇ ¼¼Æ÷°£±³ º¹ÇÕüÀÌ´Ù. ÀÌ·¯ÇÑ Á¶Á÷°ú ÀÚ°¡ Ç×ü°¡ ¹ÝÀÀÇϸé, ¼¼Æ÷ °áÇÕÀÌ ÆÄ±«µÇ¾î »óÆÐÀÇ ºÐ¸®°¡ ¾ß±âµÈ´Ù. À¯ÀüÀû ¿äÀÎÀÌ ÀÌ Áúȯ°ú °ü·Ã ÀÖ´Ù. ½É»ó¼º õÆ÷âÀÇ Ç¥ÇÇ ¹× Á¡¸· ¼Ò°ßÀº ÀϽÃÀûÀ̸ç, ¸¼Àº ¼ö¾×À¸·Î ä¿öÁø ¼Ò¼öÆ÷ ¹× ¼öÆ÷°¡ ³ªÅ¸³µ´Ù°¡ ÅÍÁüÀ¸·Î¼­ ±Ë¾çÀÌ µÇ´Âµ¥ ºÎºÐÀûÀ¸·Î´Â À¯¾àÇÑ ¸·À¸·Î µ¤¿©Áø °ÍÀ» º¼ ¼ö ÀÖ´Ù. ´ëºÎºÐÀÇ È¯ÀÚ´Â Áß³â ÀÌÈÄ¿¡ ³ªÅ¸³ªÁö¸¸ ¾î¸°À̳ª ÀþÀºÀÌ¿¡°Ôµµ ¹ß»ý ÇÒ ¼ö ÀÖ´Ù. ´ëºÎºÐÀÇ ÀÚ°¡ ¸é¿ª Áúȯ°ú ¸¶Âù°¡Áö·Î Ä¡·á´Â ÄÚ¸®Æ¼ÄÚ ½ºÅ×·ÎÀ̵带 ±¹¼Ò µµÆ÷ ¹× Àü½Å Åõ¿©ÇÏ´Â µî ¸é¿ª¾ïÁ¦Á¦¿¡ ÀÇÁ¸ÇÑ´Ù.
  • severe, painful, chronic arthritis
    ½ÉÇÑ ÅëÁõ¼º ¸¸¼º °üÀý¿°
  • Abbe-Zeiss counting cell
    ¾Ðº£-ÀÚÀ̽º Ç÷±¸ °è»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
chronic follicular conjunctivitis Indolent inflammation of the conjunctiva, with discrete follicles in fornices that may be infective, toxic, or irritant in nature.
(05 Mar 2000)
chronic glaucoma A disorder which is characterised by increased pressure within the eyeball. This occurs secondary to the chronic blockage of normal fluid circulation within the eye. Increased pressure within the eye can cause damage to the optic nerve and eventual blindness. Glaucoma is the leading cause of blindness.
Symptoms include decreased vision, halos around lights (worse at night) and mild chronic headaches. Treatment is generally with beta-blocker eyedrops.
(27 Sep 1997)
chronic glomerulonephritis Glomerulonephritis that presents with persisting proteinuria, chronic renal failure, and hypertension, of insidious onset or as a late sequel of acute glomerulonephritis; the kidneys are symmetrically contracted and granular, with scarring and loss of glomeruli and the presence of tubular atrophy and interstitial fibrosis.
Synonym: chronic nephritis.
(05 Mar 2000)
chronic granulomatous disease <disease> Chronic granulomatous disease is usually fatal in childhood, in which the production of hydrogen peroxide by phagocytes does not occur because of a lesion in an NADP dependent oxidase.
Catalase negative bacteria are not killed and there is no luminol enhanced chemiluminescence when the cells are tested. The absence of the oxygen dependent killing mechanism is not itself fatal but seriously compromises the primary defense system.
at least three separate lesions can cause the syndrome, the commonest being a defect in plasma membrane cytochrome.
Acronym: CGD
(12 Jan 1998)
chronic granulomatous disease of childhood <radiology> Disorder of phagocytosis, two forms: X-linked recessive, autosomal recessive, usually fatal in childhood, infection by nonpathogenic organisms (catalase positive), pneumonia, osteomyelitis, diarrhoea, abdominal pain Findings: recurrent pneumonia (resolves incompletely, with abscess formation), adenopathy (big hila), hepatosplenomegaly, calcified granulomata in liver, spleen, lymph nodes, gastric antral narrowing (!) Cf: Chediak-Higashi syndrome More info: chronic granulomatous disease
(12 Dec 1998)
chronic haemorrhagic villous synovitis <radiology> Monoarthritis, young adults, erosions on BOTH sides of joint (!), probably inflammatory, haemosiderin deposited in synovium, articular cartilage preserved (despite extensive marginal erosions; similar to gout), NO calcification Differential diagnosis: TB (associated atrophy of muscle and bone), rheumatoid arthritis (symmetrical), synovial sarcoma (with or without calcified; outside joint), synovial osteochondromatosis
(12 Dec 1998)
chronic hepatitis Any of several types of hepatitis persisting for more than six months, often progressing to cirrhosis.
Synonym: chronic active liver disease.
(05 Mar 2000)
chronic hypertensive disease The chronic accumulative effects of long-standing high blood pressure on such vital organs as the heart, kidney, and brain.
(05 Mar 2000)
chronic hypertrophic vulvitis Swelling of the vulval tissues due to lymphatic obstruction; in some cases it may be caused by filariasis, with induration or ulceration of the skin.
Synonym: elephantiasis vulvae.
(05 Mar 2000)
chronic hyperventilation syndrome <syndrome> Reduced CO2 content of the blood (hypocapnia) as a result of hyperventilation of prolonged duration; may occur in anxiety states and in some chronic organic, usually cardiovascular, disease; alkalaemia, paresthesia, and tetany may occur.
(05 Mar 2000)
chronic idiopathic jaundice <syndrome> An inherited disorder (autosomal recessive) that is characterised by long-standing mild jaundice. This occurs secondary to an abnormality in the transport of bilirubin from the liver to the biliary system. This leads to an accumulation of bilirubin in the liver. Avoidance of alcohol and medications which can affect the liver is important.
Inheritance: autosomal recessive.
(27 Sep 1997)
chronic idiopathic xanthomatosis Vague or indefinite term for inherited abnormalities of lipid metabolism leading to xanthoma formation (e.g., primary familial xanthomatosis).
(05 Mar 2000)
chronic illness An illness that has persisted for a long period of time. It is a continuing disease process.
(12 Dec 1998)
chronic inflammation An inflammation that may begin with a relatively rapid onset or in a slow, insidious, and even unnoticed manner, tends to persist for several weeks, months, or years and has a vague and indefinite termination; results when the injuring agent (or products resulting from its presence) persists in the lesion, and the host's tissues respond in a manner (or to a degree) that is not sufficient to overcome completely the continuing effects of the injuring agent.
(05 Mar 2000)
chronic inflammatory demyelinating polyneuropathy An uncommon, acquired, demyelinating sensorimotor polyneuropathy, clinically characterised by insidious onset, and slow evolution, (either steady progression or stepwise), and chronic course; symmetrical weakness is a predominant symptom, often involving proximal leg muscles, accompanied by paresthesias, but not pain; CSF examination shows elevated protein, while electrodiagnostic studies reveal evidence of a demyelinating process, primarily conduction slowing rather than block; sometimes responds to prednisone.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á